Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Devhare, Pradip B ^a   Chatterjee, Subhashis N ^a   Arankalle, Vidya A ^a   Lole, Kavita S ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CAPSID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; RANTES; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HEPATITIS E VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; BLOTTING, WESTERN; CAPSID PROTEINS; CELL LINE, TUMOR; CHEMOKINES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HEPATITIS E; HEPATITIS E VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON REGULATORY FACTOR-3; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTOME; VIRUS REPLICATION;

EID: 84877314497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063793     Document Type: Article

References (42)

1. Akira S, Uematsu S, Takeuchi O, (2006) Pathogen recognition and Innate Immunity. Cell 124: 783-801.
2. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S, (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3: 352-363.
3. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
4. Jensen S, Thomsen AR, (2012) Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 86: 2900-2910.
5. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA, (2011) Pattern recognition receptors and the innate immune response to viral infection. Viruses 3: 920-940.
6. Randall RE, Goodbourn S, (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47.
7. McInerney GM, Hedestam GBK, (2009) Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses. J Innate Immun 1: 599-606.
8. Aggarwal R, Jameel S, (2011) Hepatitis E. HEPATOLOGY. 54: 2218-2226.
9. Tam AW, Smith MM, Guerra ME, Huang CC, Bradley DW, et al. (1991) Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185: 120-131.
10. Graff J, Zhou YH, Torian U, Nguyen H, St. Claire M, et al. (2008) Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles J Virol. 82: 1185-1194.
11. Zafrullah M, Ozdener MH, Panda SK, Jameel S, (1997) The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J Virol 71: 9045-9053.
12. Ahmad I, Holla RP, Jameel S, (2011) Molecular virology of hepatitis E virus. Virus Res 161: 47-58.
13. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S, (2008) Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepatitis. 15: 910-916.
14. Yu C, Boon D, McDonald SL, Myers TG, Tomioka K, et al. (2010) Pathogenesis of hepatitis E virus and hepatitis C virus in Chimpanzees: Similarities and Differences. J Virol 84: 11264-11278.
15. Tripathy AS, Das R, Rathod SB, Arankalle VA, (2012) Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from hepatitis E infection. PLoS One 7: e31822.
16. Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA, (2012) Peripheral T regulatory cells and cytokines in hepatitis E infection. Eur J Clin Microbiol Infect Dis 31: 179-84.
17. Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, et al. (2010) Hepatitis E virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 48: 1112-1125.
18. Dong C, Zafrullah M, Mixson HT, Dai X, Liang J, et al. (2012) Suppression of interferon-α signaling by hepatitis E virus. HEPATOLOGY 55: 1324-1332.
19. Emerson SU, Nguyen H, Torian U, Purcell RH, (2006) ORF3 Protein of Hepatitis E Virus is Not Required for Replication, Virion Assembly, or Infection of Hepatoma Cells In Vitro. J Virol 80: 10457-10464.
20. Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US, (2009) Challenge studies in rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein boost and DNA-protein encapsulated in liposomes. Vaccine 27: 1032-1039.
21. Triantafilou K, Triantafilou M, (2004) Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through Toll-Like Receptor 4. J Virol 78: 11313-11320.
22. Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, et al. (2010) Release of Genotype 1 Hepatitis E Virus from Cultured Hepatoma and Polarized Intestinal Cells Depends on Open Reading Frame 3 Protein and Requires an Intact PXXP Motif. J Virol 84: 9059-9069.
23. Chatterjee SN, Devhare PB, Lole KS, (2012) Detection of Negative-Sense RNA in packaged hepatitis E virions by use of an improved strand-specific reverse transcription-PCR method. J Clin Microbiol 50: 1467-1470.
24. Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA, (2007) Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 25: 4350-4360.
25. Keskinen P, Nyqvist M, Sareneva T, Pirhonen J, Melen K, et al. (1999) Impaired antiviral response in human hepatoma cells. Virology 263: 364-375.
26. Li K, Chen Z, Kato N, Gale M Jr, Lemon SM, (2005) Distinct Poly(I-C) and virus-activated signaling pathways leading to interferon production in Hepatocytes. J Biol Chem 280: 16739-16747.
27. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, et al. (2001) Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth F R 12: 171-180.
28. Siren J, Imaizumi T, Sarkar D, Pietila T, Noah DL, et al. (2006) Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infect 8: 2013-2020.
29. Goffic RL, Bouguyon E, Chevalier C, Vidic J, Costa BD, et al. (2010) Influenza A virus protein PB1-F2 exacerbates IFN-β expression of human respiratory epithelial cells. J Immunol 185: 4812-4823.
30. Tissari J, Siren J, Meri S, Julkunen I, Matikainen S, (2005) IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J Immunol 174: 4289-4294.
31. Goffic RL, Pothlichet J, Vitour D, Fujita T, Meurs E, et al. (2007) Cutting Edge: influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178: 3368-3372.
32. Yokota SI, Okabayashi T, Fujii N, (2010) The battle between virus and host: modulation of Toll-Like Receptor signaling pathways by virus infection. Mediators of Inflammation 2010: 1-12.
33. Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, et al. (2001) CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3 might be involved in the amplification of local necroinflammatory response in the liver. HEPATOLOGY 34: 311-319.
34. Soo HM, Garzino-Demo A, Hong W, Tan YH, Tan YJ, et al. (2002) Expression of a full-length hepatitis C virus cDNA up-regulates the expression of CC chemokines MCP-1 and RANTES. Virology 303: 253-277.
35. Mogensen TH, Paludan SR, (2001) Molecular pathways in virus induced cytokine production. Microbiol Mol Biol Rev 65: 131-150.
36. Prabhu SB, Gupta P, Durgapal H, Rath S, Gupta SD, et al. (2011) Study of cellular immune response against Hepatitis E Virus (HEV). J Viral Hepat 18: 587-594.
37. Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, et al. (2008) Sequential control of Toll-like receptor dependent responses by IRAK1 and IRAK2. Nat Immunol 9: 684-691.
38. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430: 694-699.
39. Lee MS, Kim YJ, (2007) Signaling pathways downstream of pattern-recognition receptors and their crosstalk. Annu Rev Biochem 76: 447-80.
40. Rehman S, Kapur N, Durgapal H, Panda SK, (2008) Subcellular localization of hepatitis E virus (HEV) replicase. Virology 370: 77-92.
41. Karpe YA, Lole KS, (2011) Deubiquitinating activity associated with hepatitis E virus putative papain like cysteine protease. J Gen Virol 92: 2088-2092.
42. Gack MU, Shin YC, Joo CH, Urano T, Liang C, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-921.